Rapport Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
01 Jul 24 | BuyUS$1,079,575 | Synergy Capital Limited | Company | 44,032 | US$26.06 | |
10 Jun 24 | BuyUS$8,316,910 | Sofinnova Investment, Inc. | Company | 489,230 | US$17.00 | |
10 Jun 24 | BuyUS$1,183,098 | Synergy Capital Limited | Company | 69,594 | US$17.00 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 2,479,420 | 6.51% |
Hedge Funds | 2,940,283 | 7.72% |
VC/PE Firms | 16,213,208 | 42.6% |
Institutions | 16,432,432 | 43.2% |
Dilution of Shares: RAPP only recently listed within the past 12 months
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
8,104,451 | US$178.1m | 0% | 36.31% | |||
4,983,351 | US$109.5m | 0% | 0.01% | |||
3,728,738 | US$82.0m | 0% | 7.77% | |||
2,940,283 | US$64.6m | 0% | 3.09% | |||
2,895,756 | US$63.6m | 0% | 0.01% | |||
2,602,531 | US$57.2m | 0% | no data | |||
2,498,051 | US$54.9m | 0% | 12.94% | |||
1,881,968 | US$41.4m | -3.57% | 2.67% | |||
1,090,858 | US$24.0m | 0% | 0.01% | |||
980,730 | US$21.6m | 0% | 0.01% | |||
789,703 | US$17.4m | 0% | no data | |||
748,183 | US$16.4m | 0% | 0.36% | |||
592,458 | US$13.0m | 0% | 0.01% | |||
477,642 | US$10.5m | 0% | no data | |||
477,642 | US$10.5m | 0% | no data | |||
350,000 | US$7.7m | 0% | 0.18% | |||
315,667 | US$6.9m | 0% | no data | |||
290,831 | US$6.4m | 0% | no data | |||
233,735 | US$5.1m | 0% | 20.37% | |||
208,910 | US$4.6m | 0% | 0.51% | |||
201,748 | US$4.4m | 0% | no data | |||
197,426 | US$4.3m | 0% | no data | |||
171,100 | US$3.8m | 0% | 0.04% | |||
157,941 | US$3.5m | 0% | no data | |||
116,782 | US$2.6m | 0% | no data |